What Determines Vaccine Hesitancy: Recommendations from Childhood Vaccine Hesitancy to Address COVID-19 Vaccine Hesitancy · Rodrigues F, Block S, Sood S

4. Discussion

This study aimed to understand what works to address vaccine hesitancy and ultimately increase vaccine uptake. These insights provided the basis for the development of a new conceptual model intended to address this complex issue. After reviewing the literature on the determinants and factors of vaccine hesitancy and vaccine uptake, and the role of FLWs and IPC/counseling, we realized most of the constructs in our conceptual model could be adapted to COVID-19 vaccinations. A primary difference is that instead of only deciding whether to vaccinate their child, individuals also decide for themselves. The reasons for vaccine hesitancy vary in each community or country, and now the public health community is tasked with promoting vaccine uptake among eligible adults, caregivers, and their children aged five years and older [34]. Currently, only 56.5% of the global population is partially vaccinated against COVID-19 [35]. The fewer vaccinated people, the more risk exists to spread disease. Therefore, addressing COVID-19 vaccine hesitancy for those five years old and above is crucial to mitigate the number of coronavirus cases and protect the population’s health.

The core-provider characteristics included in our model can be used to develop role-model provider portfolios for vicarious learning and can be included in training to build the capacity of FLWs, tasked with counseling vaccine recipients. The caregiver or vaccine recipient characteristics can be used to develop tailored interventions for different categories of audiences based on the specific constructs that need to be addressed.

In addition to the three conceptual models presented earlier, previous research has showcased the correlation between sociodemographic factors and vaccine hesitancy [2,36]. Specifically, this includes correlations between vaccine hesitancy and education, income, gender, race, and/or marital status [15,36,37,38,39]. However, some of these factors, including gender, are not consistently correlated with vaccine hesitancy and may be context- or vaccine-specific [36]. To address vaccine hesitancy, there needs to be an understanding of the psychological and social dimensions, with appropriate measures to monitor the shift in behavior accompanied by reliable and valid outcome measures [37,38,39]. The ability to understand these dimensions and contextual adaptation is especially important for COVID-19 vaccine hesitancy.

Although a majority of constructs in our conceptual model can be applied to hesitancy of the COVID-19 vaccine, constructs will need to be adapted to be relevant in certain contexts, while others may not be relevant at all. For instance, when receiving vaccines and waiting in a long line at a grocery store pharmacy, the provider may be unable to engage in extended conversations with vaccine-hesitant caregivers or recipients. As a result, the construct of interpersonal communication and its suggested techniques should be modified. This includes shortening their recommendation or explanation that addresses their concerns. Alternatively, follow-up is a construct that might or might not be applicable for this setting. However, if the vaccine is scheduled and administered in a health clinic with a vaccine recipient’s primary care physician, then these constructs should apply.

Overall, given the setting, organizational needs, or health provider needs, the provider constructs in the newly developed conceptual model will vary in how they interact and their relevance for COVID-19 vaccination. However, regardless of where the vaccine is being administered or how much time the health provider has to administer the vaccine, the provider should always be empathetic, respectful, actively listening to the vaccine recipient, culturally competent, and be able to engage in interpersonal communication. The health provider should also be knowledgeable about the vaccine regarding possible allergies, effectiveness, and potential side effects.

Depending on the setting, the constructs for caregivers or vaccine recipients will also vary in relevance for COVID-19 vaccination. However, special attention should be given to convenience (access, cost, time, and location), trust in providers, and confidence. The vaccine recipient should be able to access the COVID-19 vaccine (either one dose or both) and the subsequent booster dose at a low cost if any. Furthermore, the vaccine recipient needs to have trust in the health provider. Having trust in the health provider can make the vaccination process smoother and provide a sense of ease for the vaccine recipient [40]. Finally, having confidence in the effectiveness and safety of vaccines, the system delivering them, the proficiency of the health providers, and the motivations of the leaders and policymakers is essential in making the vaccination process a seamless one [19].

The conceptual model’s constructs must also be applied to address health provider vaccine hesitancy. Similar to caregivers and vaccine recipients, health provider vaccine hesitancy is not new or isolated to the COVID-19 vaccine and varies by behavioral, social, and other contextual factors. Health providers’ confidence in the vaccines, knowledge, and whether they feel a responsibility to protect and promote the public’s health versus personal autonomy influence their vaccine behaviors and choices [41,42,43,44]. Misleading information or misinformation and low perceived risk (complacency) also contribute to vaccine hesitancy [41,42,43,44]. These constructs must be examined and addressed to promote vaccine uptake among health providers and ensure their role in encouraging their patients to get vaccinated. Specifically, health providers’ knowledge of vaccines [43], confidence in vaccines [41,43,45], and their recommendations are strong predictors of caregiver and vaccine recipients’ decisions regarding vaccination [45].

It is imperative to train health workers and provide them with the skills and techniques to interact with vaccine-hesitant colleagues, caregivers, and vaccine recipients to increase vaccination uptake [5,14]. Organizations trying to tackle the issue of vaccine hesitancy must consider the influx of a variety of factors that affect the demand for immunizations. Health providers should participate in IPC/counseling trainings so that they are prepared to draw upon the conceptual models’ identified constructs to educate their clients, offer strong recommendations, and respond to questions regarding safety, efficacy, and the role in preventing the spread of communicable diseases. Training workshops should be held at a convenient time for them, be culturally appropriate, and in a space that encourages authentic communication [20,27]. Resources should also be provided to health providers to use in the future, including but not limited to job aids, technical assistance, and access to trusted sources for referral (such as the CDC or NIH website). Health providers must encourage the acceptance and uptake of the COVID-19 vaccine to their clients as well as on media platforms and work to negate misleading information [30,46].

Training health workers is a key to addressing vaccine hesitancy among health workers, caregivers, and vaccine recipients, yet there must also be a monitoring and evaluation framework in place to determine the efficacy of this training. Conducting routine monitoring of vaccine hesitancy is critical in identifying concerns regarding vaccinations earlier rather than later [38]. It is crucial since vaccine hesitancy is constantly evolving. It is imperative to better understand the contextual and socio-ecological influences contributing to vaccine hesitancy to engage the population, health providers, and local and national leaders [37,38]. This will lead to an increase in the uptake of the COVID-19 vaccine.

Strengths, Limitations, and Future Research

This study has several strengths. A key strength is that our conceptual model can be used for situation analysis purposes, to understand and rank the key determinants of vaccine hesitancy among providers and vaccine recipients. Given its adaptability, it can serve a monitoring and evaluation function in various settings. Monitoring looks at the extent to which a program is being implemented according to plan and change is happening. Evaluation measures effectiveness by comparing locations (intervention and comparison) or changes over time. Measuring vaccine hesitancy is imperative to understand if current programs are indeed increasing vaccine uptake.

Another strength is the valid and reliable construct definitions for each potential indicator. Our next step is to develop measurement tools based on our construct definitions. Tools with variables to measure all of the constructs in our model are needed to assess the scope and scale of vaccine hesitancy issues by vaccine type and context. A tool that can be adapted globally would be ideal because it allows comparability across countries [38]; our conceptual model will allow for the necessary modifications.

There are also several limitations to this study. We relied on English language publications to select models and definitions of key terms, given the global nature of COVID 19 related research, it is possible that we failed to consider relevant literature published in other languages. The conceptual model has not yet been formally validated through pilot studies. To date, validation has been based on feedback from specific vaccine experts in the European and Central Asia Region. Moreover, COVID-19 vaccine hesitancy may continue to evolve as new research emerges. As a result, additional constructs that have not been identified in this study should be considered prior to the implementation of this conceptual model. Lastly, we realize that this study does not provide one answer to address vaccine hesitancy and increase vaccine uptake. It is our hope that future research can build on the contents of this paper for future implementation, monitoring, and evaluation purposes.